USA flag logo/image

An Official Website of the United States Government

FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R44GM100560
Solicitation Year:
2012
Solicitation Topic Code:
NIGMS
Solicitation Number:
PA11-096
Small Business Information
NEW ENGLAND BIOLABS, INC.
240 County Road IPSWICH, MA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2012
Title: FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
Agency: HHS
Contract: 4R44GM100560-02
Award Amount: $874,892.00
 

Abstract:

DESCRIPTION (provided by applicant): This project aims to find novel restriction enzymes that will be useful in many aspects of molecular biology research. One particular focus will be on restriction endonucleases that are able to recognize modified DNA, especially DNA containing 5-methylcytosine and 5- hydroxymethycytosine since such enzymes have many potential applications in epigenetics research. Enzymes recognizing these modified bases are known to occur in bacterial and archaea strains and in the past,many have been found by random biochemical screening. In the proposed project, the discovery of potential new enzymes will use bioinformatics techniques and take advantage of the large number of currently sequenced prokaryotic genomes, both completely sequenced genome and shotgun sequences. The project will identify good candidates and then use biochemical methods to characterize them. In addition to commercializing any useful enzymes that are found from this screen, the information gained about the biochemical function of the restriction enzymes discovered will be invaluable for genome annotation and will have practical implications for researchers working with pathogenic organisms. The latter will result from our efforts to characterize the restriction-modification systems in pathogens and identify those systems which need either to be knocked out or circumvented by prior modification prior to transformation. Thus, the results of this research will have immediate implications for the fields of epigenetics,pathogenesis and genome annotation.

Principal Investigator:

Richard J. Roberts
978-380-7405
roberts@neb.com

Business Contact:

Brian Tinger
978-380-7485
tinger@neb.com
Small Business Information at Submission:

NEW ENGLAND BIOLABS, INC.
240 County Road Ipswich, MA -

EIN/Tax ID: 104263196
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No